We are scientists, engineers, and clinical manufacturing experts working relentlessly to scale Regenerative Medicines to millions of patients. We noticed these therapies were showing they could cure Parkinson's, blindness, even spinal cord injury - and yet most patients wouldn't never be able to afford or get access to them, because they're produced manually. So we decided to fix that with automated production.

Six years ago, we started automating production of stem cell derived cells such as heart and brain tissue for R&D use in the largest US Pharma companies (including 3 of top 20) - and we’ve taken our iDEM automated technology through 6 generations of refinement and iteration since.

Now, we're building and operating fully automated cell manufacturing sites to scale production of Regenerative Medicines at low cost to millions of patients.

We’ve raised over $24M, including from founders of multibillion dollar companies like Wayve, Dropbox, Segment, and Mercury - and execs from companies like Sana, BMS, and Revolut. What we've done so far will be game-changing for patients, and we still have plently more to build and do.